Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.34 |
| ▸ | KCNE1 | P15382 | 5/20 | 0.32 |
| ▸ | KCNQ1 | P51787 | 5/20 | 0.32 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6559500 | 0.87 | NPSR1 (0.38) | KCNA5SMN1; SMN2NPSR1KCNE1KCNQ1 | |
| SCHEMBL6559927 | 0.83 | KCNA5 (0.41) | KCNA5ALDH1A1KCNE1KCNQ1TBXAS1 | |
| SCHEMBL6558561 | 0.82 | KCNE1 (0.34) | KCNA5NPSR1KCNE1KCNQ1TBXAS1 | |
| SCHEMBL6558501 | 0.82 | KCNE1 (0.45) | KCNA5KCNE1KCNQ1TBXAS1TBXA2R | |
| SCHEMBL7826231 | 0.79 | KCNE1 (0.36) | KCNA5KCNE1KCNQ1TBXAS1TBXA2R | |
| SCHEMBL6559913 | 0.77 | TDP1 (0.38) | KCNA5ALDH1A1PKMHTTRECQL | |
| SCHEMBL6559607 | 0.77 | KCNE1 (0.47) | KCNA5KCNE1KCNQ1TBXAS1TBXA2R | |
| SCHEMBL6559205 | 0.76 | SMN1; SMN2 (0.38) | KCNA5ALDH1A1HTTSMN1; SMN2NPSR1 | |
| SCHEMBL6560005 | 0.75 | KCNE1 (0.43) | KCNA5ALDH1A1KCNE1KCNQ1TBXAS1 | |
| SCHEMBL6559550 | 0.74 | MEN1 (0.37) | KCNA5ALDH1A1KCNE1KCNQ1TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0807629-B1 | Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them | AVENTIS PHARMA GMBH (DE) | 2004-03-03 | — | — | EP | disclosed |
| US-6191164-B1 | POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 2001-02-20 | — | — | US | disclosed |
| EP-0807629-A1 | Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-11-19 | — | — | EP | disclosed |